← Open Payments lookup

HOLLY SHOEMAKER: Open Payments

NPI 1396376596 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,713 in 85 payments from 18 companies in 2025. Trend: 2023 $1,446 · 2024 $1,559 · 2025 $1,713

Food & beverage: $1,713
CompanyPaymentsAmount
Novo Nordisk Inc13$245
ABBVIE INC.11$223
AstraZeneca Pharmaceuticals LP10$193
PFIZER INC.9$171
Bayer Healthcare Pharmaceuticals Inc.7$144
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$106
Lundbeck LLC4$105
Otsuka America Pharmaceutical, Inc.4$100
Amgen Inc.6$92
Vanda Pharmaceuticals Inc.4$92

Products named: REXULTI, Ozempic, VRAYLAR, Kerendia, AIRSUPRA, CAPLYTA, ELIQUIS, FANAPT.

Industry payments across GA — which companies pay providers there.